Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.